Salman Alzahrani studied biomedical science and laboratory medicine, and started his career doing the work the rest of the sector talks about: running assays, validating methods and finding out which instruments truly hold up under a real sample load.
That background shapes what he looks for in a localisation announcement. A memorandum to manufacture in the Kingdom is a policy document. A working line is built from validated methods, trained technologists, a supply chain for reagents and a quality system that passes an audit, the work that follows the press release. He covers Saudi institutions, localisation policy and public procurement on the assumption that the interesting question is always what happens after the signing ceremony.
He is Saudi, works in the Kingdom, and reviews every piece of Arabic-language material A7i publishes before it ships. He takes the long view of what is being built, on the basis that a biotechnology sector is a generational project and most of it will be judged by the generation that comes to work in it next.
Expertise
- Saudi healthcare institutions
- Laboratory medicine
- Localisation policy
- Public procurement
- Arabic-language review
Education
- Bachelor of Science, Biomedical Science and Laboratory Medicine
Other professional roles
- Solutions Engineer, Wallace Biotechnologies.
Elsewhere
Articles
- Localisation is putting real plant in the ground across the Kingdom
- One Gulf regulator carries international weight. Here is how all six work
- Four institutions hold most of the Gulf's life-science capability
- How foreign companies establish a route into Saudi Arabia
- Establishing a route into the UAE
- Establishing a route into Qatar